Medline ® Abstract for Reference 66
of 'Complications of prosthetic heart valves'
66
TI
Recombinant human erythropoietin use in hemolytic anemia due to prosthetic heart valves: a promising treatment.
AU
Hirawat S, Lichtman SM, Allen SL
SO
Am J Hematol. 2001;66(3):224.
Two patients are reported with hemolytic anemia due to red blood cell fragmentation in association with prosthetic heart vales. They were treated with erythropoietin which eliminated the need for packed red blood cell transfusion.
AD
Don Monti Division of Medical Oncology, Department of Medicine, North Shore University Hospital-New York University School of Medicine, Manhasset, New York 11030, USA.
PMID